Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for NYU Langone's Tisch Hospital located at 550 1St Ave, New York, NY, 10016 & includes data from NPIs 1366541989, 1659470276, 1801992631
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for NYU Langone's Tisch Hospital compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,905 | 2,830 | ||||||||||
| Surgical | 1,352 | 1,337 | ||||||||||
| Non Surgical | 1,553 | 1,493 | ||||||||||
| Orthopedics | 603 | 597 | ||||||||||
| Cardiovascular | 490 | 477 | ||||||||||
| General Medicine | 338 | 312 | ||||||||||
| General Surgery | 298 | 293 | ||||||||||
| Gastroenterology & Endocrinology | 219 | 216 | ||||||||||
| Neurology | 182 | 175 | ||||||||||
| Pulmonology | 180 | 176 | ||||||||||
| Urology | 174 | 170 | ||||||||||
| Oncology & Hematology | 130 | 128 | ||||||||||
| Spine | 119 | 119 | ||||||||||
| Colorectal | 71 | 70 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 34 | 34 | ||||||||||
| Psychiatry & Mental Disorders | 32 | 29 | ||||||||||
| Obstetrics & Gynecology | 21 | 20 | ||||||||||
| Dermatology | 14 | 14 |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 559: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| DRG 516: OTHER MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE O.R. PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Fractures Of Hip And Pelvis | ||||||||||||
| Medical Back Problems |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 267: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 220: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Coronary Bypass | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Cardiothoracic Procedures | ||||||||||||
| DRG 229: OTHER CARDIOTHORACIC PROCEDURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Peripheral Vascular Disorders |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| Complications Of Treatment |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Craniotomy And Endovascular Intracranial Procedures | ||||||||||||
| DRG 027: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 025: CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| DRG 165: MAJOR CHEST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Extracranial Procedures | ||||||||||||
| DRG 039: EXTRACRANIAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other O.R. Procedures For Injuries | ||||||||||||
| Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| Postoperative Or Post-Traumatic Infections With O.R. Procedure | ||||||||||||
| Ventricular Shunt Procedures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Digestive System Diagnoses | ||||||||||||
| DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Gastrointestinal Disorders And Peritoneal Infections | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Disorders Of Biliary Tract | ||||||||||||
| Endocrine Disorders |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seizures | ||||||||||||
| DRG 101: SEIZURES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 100: SEIZURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 178: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Embolism | ||||||||||||
| DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures | ||||||||||||
| Kidney Transplant | ||||||||||||
| DRG 652: KIDNEY TRANSPLANT | ||||||||||||
| Major Male Pelvic Procedures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Digestive Malignancy | ||||||||||||
| Malignancy Of Hepatobiliary System Or Pancreas | ||||||||||||
| DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Red Blood Cell Disorders | ||||||||||||
| Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
| Respiratory Neoplasms |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Combined Anterior/Posterior Spinal Fusion | ||||||||||||
| Cervical Spinal Fusion | ||||||||||||
| Spinal Fusion Except Cervical With Spinal Curvature / Malignancy / Infection Or Extensive Fusions | ||||||||||||
| DRG 457: SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE OR MALIGNANCY OR INFECTION OR EXTENSIVE FUSIONS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Back And Neck Procedures, Except Spinal Fusion, Or Disc Devices/Neurostimulators | ||||||||||||
| DRG 519: BACK AND NECK PROCEDURES EXCEPT SPINAL FUSION WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures | ||||||||||||
| DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures | ||||||||||||
| DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | New York Total Hospitalizations (Jul 2017 to Sep 2017) | New York Total Hospitalizations After Exclusion | New York Total Users | New York SNF Discharge Rate (%) | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |